Clostridial Colitis – Causes, Symptoms and Treatment
Clostridial colitis is an inflammation of the large intestine caused by the bacterium Clostridioides difficile. It most commonly occurs after antibiotic use and can cause severe diarrhea.
Things worth knowing about "Clostridial Colitis"
Clostridial colitis is an inflammation of the large intestine caused by the bacterium Clostridioides difficile. It most commonly occurs after antibiotic use and can cause severe diarrhea.
What is Clostridial Colitis?
Clostridial colitis is an inflammation of the colon (large intestine) caused by the bacterium Clostridioides difficile (formerly known as Clostridium difficile). The condition is also referred to as a C. difficile infection (CDI). The bacterium produces toxins that damage the lining of the intestine, leading to symptoms that can range from mild to life-threatening. Clostridial colitis is one of the most common healthcare-associated infections worldwide.
Causes and Risk Factors
Clostridioides difficile is a spore-forming bacterium found naturally in the environment and in the gut of some healthy individuals without causing harm. Problems arise when the natural balance of the gut microbiome is disrupted. Key risk factors include:
- Antibiotic therapy: The most common trigger. Antibiotics destroy beneficial gut bacteria, allowing C. difficile to multiply uncontrolled.
- Hospital stays: C. difficile spores spread easily in healthcare settings.
- Older age: Adults over 65 are at significantly higher risk.
- Weakened immune system: Due to conditions such as HIV or medications such as corticosteroids.
- Proton pump inhibitors (PPIs): Acid-suppressing medications may increase susceptibility.
- Previous C. difficile infection: Recurrence rates are notably higher in those who have had a prior episode.
Symptoms
Symptoms can vary in severity from mild to life-threatening and typically include:
- Watery diarrhea (three or more times per day)
- Cramping abdominal pain
- Nausea and loss of appetite
- Fever
- In severe cases: bloody stools and significant dehydration
A particularly severe form is pseudomembranous colitis, characterized by the formation of yellowish-white plaques (pseudomembranes) on the intestinal lining. In rare cases, a life-threatening complication called toxic megacolon -- an extreme dilation of the colon -- can develop.
Diagnosis
Diagnosis of clostridial colitis involves several steps:
- Stool testing: Detection of C. difficile toxins (Toxin A and B) or the organism itself via enzyme immunoassay (EIA) or PCR test.
- Colonoscopy: In unclear or severe cases, a colonoscopy may reveal pseudomembranes or other mucosal changes.
- Blood tests: Elevated inflammatory markers such as CRP and white blood cell count can indicate a severe course of the disease.
Treatment
Discontinuation of Triggering Antibiotics
Where medically appropriate, the antibiotic that triggered the infection should be discontinued to allow the natural gut flora to recover.
Antibiotic Therapy
The infection itself is treated with antibiotics specifically active against C. difficile:
- Vancomycin (oral): First-line treatment for moderate to severe disease.
- Fidaxomicin: A newer antibiotic with a lower recurrence rate, particularly recommended for high-risk patients.
- Metronidazole: Now reserved for mild cases or as an adjunct therapy.
Fecal Microbiota Transplant (FMT)
For recurrent infections, a fecal microbiota transplant (FMT) may be performed. This procedure involves transferring gut microbiota from a healthy donor to the patient to restore a balanced intestinal environment. FMT has shown very high success rates in treating recurrent CDI.
Supportive Measures
- Adequate fluid intake and electrolyte replacement
- Intravenous fluids in severe or hospitalized cases
- Surgical intervention in life-threatening situations such as toxic megacolon
Prevention
Preventing clostridial colitis focuses on several key strategies:
- Responsible and targeted use of antibiotics (antibiotic stewardship)
- Thorough hand hygiene with soap and water, as alcohol-based hand sanitizers do not reliably kill C. difficile spores
- Isolation of infected patients in healthcare settings
- Disinfection of surfaces with sporicidal agents
References
- Surawicz CM et al. - Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections. American Journal of Gastroenterology, 2013; 108(4):478-498.
- Leffler DA, Lamont JT - Clostridium difficile Infection. New England Journal of Medicine, 2015; 372(16):1539-1548.
- McDonald LC et al. - Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 2018; 66(7):987-994.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Clostridial Colitis-en